Clinical trial
Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses
NCT02936622 is registered in ClinicalTrials.gov with Cook Group Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses
- Lead sponsor
- Cook Group Incorporated
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 21, 2017
- Completion date
- October 25, 2023
- Enrollment
- 176 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral arterial disease (pad)